文献速递血栓与止血

COVID-19患者血小板蛋白质组特征改变及整合素αIIbβ3活化受损

Alterations in platelet proteome signature and impaired platelet integrin αIIbβ3 activation in patients with COVID-19.
PubMed 文献 · J Thromb Haemost · 2023-01-28

该研究比较了COVID-19住院患者与健康对照者的血小板蛋白质组、功能反应及血小板-中性粒细胞聚集体,发现患者血小板有858种蛋白表达改变,颗粒分泌蛋白升高而血小板活化蛋白降低,基础状态血小板-中性粒细胞聚集体水平高且可被阻断P-selectin破坏,提示存在两种血小板群体。

要点

  • COVID-19患者血小板蛋白质组有858种蛋白表达改变(共定量5773种)。
  • 患者血小板颗粒分泌蛋白升高,血栓素受体和蛋白激酶Cα等活化蛋白降低。
  • 患者基础状态血小板-中性粒细胞聚集体水平高,阻断P-selectin可破坏该关联。

核心结论

  • 研究数据提示COVID-19患者存在两种血小板群体:一种循环血小板蛋白质组改变且功能反应降低,另一种为表达P-selectin的中性粒细胞相关血小板。
  • 血小板驱动的血栓炎症可能是增强COVID-19患者血栓风险的关键因素之一。

研究设计与样本

  • 采用串联质谱标签蛋白质组学分析、Western blotting和流式细胞术,比较COVID-19住院患者与健康对照者的血小板蛋白质组、血小板功能反应及血小板-中性粒细胞聚集体。

主要发现

  • COVID-19患者血小板蛋白表达谱不同,5773种定量蛋白中858种改变。
  • COVID-19患者血小板中COVID-19血浆标志物水平升高。
  • 基因本体通路分析显示颗粒分泌蛋白水平升高,而血小板活化蛋白如血小板生成素受体和蛋白激酶Cα水平降低。
  • 基础状态下COVID-19患者血小板磷脂酰丝氨酸暴露增强,整合素αIIbβ3活化和P-selectin表达未改变。
  • 激动剂刺激后COVID-19患者整合素αIIbβ3活化和磷脂酰丝氨酸暴露降低,而P-selectin表达未降低;COVID-19患者基础状态下血小板-中性粒细胞聚集体水平高于对照,阻断P-selectin可破坏该关联。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Patients with COVID-19 are at increased risk of thrombosis, which is associated with altered platelet function and coagulopathy, contributing to excess mortality. OBJECTIVES: To characterize the mechanism of altered platelet function in COVID-19 patients. METHODS: The platelet proteome, platelet functional responses, and platelet-neutrophil aggregates were compared between patients hospitalized with COVID-19 and healthy control subjects using tandem mass tag proteomic analysis, Western blotting, and flow cytometry. RESULTS: COVID-19 patients showed a different profile of platelet protein expression (858 altered of the 5773 quantified). Levels of COVID-19 plasma markers were enhanced in the platelets of COVID-19 patients. Gene ontology pathway analysis demonstrated that the levels of granule secretory proteins were raised, whereas those of platelet activation proteins, such as the thrombopoietin receptor and protein kinase Cα, were lowered. Basally, platelets of COVID-19 patients showed enhanced phosphatidylserine exposure, with unaltered integrin αIIbβ3 activation and P-selectin expression. Agonist-stimulated integrin αIIbβ3 activation and phosphatidylserine exposure, but not P-selectin expression, were decreased in COVID-19 patients. COVID-19 patients had high levels of platelet-neutrophil aggregates, even under basal conditions, compared to controls. This association was disrupted by blocking P-selectin, demonstrating that platelet P-selectin is critical for the interaction. CONCLUSIONS: Overall, our data suggest the presence of 2 platelet populations in patients with COVID-19: one of circulating platelets with an altered proteome and reduced functional responses and another of P-selectin-expressing neutrophil-associated platelets. Platelet-driven thromboinflammation may therefore be one of the key factors enhancing the risk of thrombosis in COVID-19 patients.

来源:J Thromb Haemost,查看原文。版权归原作者所有。

引用

  1. Goudswaard LJ, Williams CM, Khalil J, et al. Alterations in platelet proteome signature and impaired platelet integrin αIIbβ3 activation in patients with COVID-19. J Thromb Haemost. 2023. PMID: 36716966. doi:10.1016/j.jtha.2023.01.018

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。